Skip to main content

Table 2 A table summarising the complications and adverse events of all included studies

From: Intra-arterial anaesthetics for pain control in arterial embolisation procedures: a systematic review and meta-analysis

Study Type of Study Complications & Adverse events
Abusedera et al. 2014 RCT None reported.
Duvnjak and Andersen 2020 RCT None reported.
Hartnell et al. 1999 Observational (retrospective & prospective) None reported.
Katsumori et al. 2020 Observational (retrospective) None reported.
Keyoung et al. 2001 RCT Trial concluded prematurely. 7/10 of those receiving lidocaine had moderate to severe vasospasm with restricted flow for 10–20 min.
Lee et al. 2001 RCT One patient had a transient (~ 10 min) decrease in blood pressure (from 120/80 mmHg to 90/60 mmHg) after lidocaine injection.
Molgaard et al. 1990 Observational (retrospective & prospective) None reported.
Noel-Lamy et al. 2017 RCT Statistically significant reduction (p = 0.045) in proportion of patients with complete infarction of leiomyoma in those receiving lidocaine during UFE (38.9%) (n = 18) compared to those receiving lidocaine after UFE (77.8%) (n = 18) and control group (75%) (n = 20).
Zhan et al. 2005 RCT None reported